Division of Hearing and Balance Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo, 152-8902, Japan.
Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan.
Orphanet J Rare Dis. 2022 Mar 5;17(1):114. doi: 10.1186/s13023-022-02262-4.
Heterogeneous genetic loci contribute to hereditary hearing loss; more than 100 deafness genes have been identified, and the number is increasing. To detect pathogenic variants in multiple deafness genes, in addition to novel candidate genes associated with hearing loss, whole exome sequencing (WES), followed by analysis prioritizing genes categorized in four tiers, were applied.
Trios from families with non-syndromic or syndromic hearing loss (n = 72) were subjected to WES. After segregation analysis and interpretation according to American College of Medical Genetics and Genomics guidelines, candidate pathogenic variants in 11 previously reported deafness genes (STRC, MYO15A, CDH23, PDZD7, PTPN11, SOX10, EYA1, MYO6, OTOF, OTOG, and ZNF335) were identified in 21 families. Discrepancy between pedigree inheritance and genetic inheritance was present in one family. In addition, eight genes (SLC12A2, BAIAP2L2, HKDC1, SVEP1, CACNG1, GTPBP4, PCNX2, and TBC1D8) were screened as single candidate genes in 10 families.
Our findings demonstrate that four-tier assessment of WES data is efficient and can detect novel candidate genes associated with hearing loss, in addition to pathogenic variants of known deafness genes.
多种遗传基因座与遗传性听力损失有关;已鉴定出 100 多个耳聋基因,且数量还在增加。为了检测多个耳聋基因中的致病变异,除了与听力损失相关的新候选基因外,还应用了全外显子组测序(WES),然后对按四个层次分类的基因进行优先分析。
对来自非综合征性或综合征性听力损失家庭的三核苷酸(n=72)进行了 WES。根据美国医学遗传学与基因组学学院的指导方针进行分离分析和解释后,在 21 个家庭中鉴定出 11 个先前报道的耳聋基因(STRC、MYO15A、CDH23、PDZD7、PTPN11、SOX10、EYA1、MYO6、OTOF、OTOG 和 ZNF335)中的候选致病性变异。一个家庭的系谱遗传与遗传遗传存在差异。此外,在 10 个家庭中筛选出 8 个基因(SLC12A2、BAIAP2L2、HKDC1、SVEP1、CACNG1、GTPBP4、PCNX2 和 TBC1D8)作为单一候选基因。
我们的研究结果表明,WES 数据的四层评估是有效的,除了已知耳聋基因的致病变异外,还可以检测与听力损失相关的新候选基因。